Genomic insights into phage SGP007 reveal a potent therapeutic candidate for targeted control of salmonellosis in poultry

Key Points

• Phage SGP007 demonstrates significant efficacy in targeting salmonellosis strains, revealing its potential as a therapeutic candidate.
• The genomic insights provide a deeper understanding of phage mechanisms and their application in poultry.
• Observational analysis across poultry facilities suggests that implementing phage therapy could reduce salmonellosis outbreaks effectively.
• Further research is needed to confirm the clinical effectiveness of phage therapy for broader applications beyond poultry.